Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04000841 · ClinicalTrials.gov registry record · NA

Culturally Responsive Stress Reduction: A Mobile Mindfulness Application for African Americans (CRSR)

A NA study of Behavior, sponsored by IRIS Media.

Completed
Registry status
NA
Development phase
212
Enrollment target
1
Study location

NCT04000841 is a NA study of Behavior that has completed, run by IRIS Media. The registered enrollment target is 212 participants, below the 4,856-participant average among 23 other Behavior trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04000841, a NA study of Behavior, has completed, sponsored by IRIS Media.

COMPLETED
Registry status
NA
Development phase
212 participants
Enrollment target
1
Study location

Study Summary

Over a 12-week period the investigators will test whether, compared to the Waitlist-Control (WC) condition, administration of the full CRSR intervention improves participants self-reported outcomes of stress, self-efficacy, mindfulness, use of mindfulness strategies, and knowledge. The investigators also will examine the usability, cultural relevance, and user satisfaction.

Conditions Studied

Interventions

  • BEHAVIORAL Mindful You mobile app

Study Locations (1)

Oregon

  • IRIS Educational Media - Eugene

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 2021-02-01
Est. Completion 2022-02-22
Phase NA

Sponsor

IRIS Media

3 total trials

What the Registry Record Tells You About NCT04000841

The ClinicalTrials.gov registry entry for NCT04000841 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,856-participant average among 23 other Behavior trials with a reported enrollment target (96% lower). The listed sponsor is IRIS Media, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Behavior appearing as the primary indexed condition, and to 1 intervention - of which Mindful You mobile app is the first listed.

NCT04000841 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT04000841 about?

NCT04000841 is a clinical study titled "Culturally Responsive Stress Reduction: A Mobile Mindfulness Application for African Americans (CRSR)". Over a 12-week period the investigators will test whether, compared to the Waitlist-Control (WC) condition, administration of the full CRSR intervention improves participants self-reported outcomes of stress, self-efficacy, mindfulness, use of mindfulness strategies, and knowledge. The investigators...

What is the current status of trial NCT04000841?

This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2021-02-01. Estimated completion is 2022-02-22.

What conditions does trial NCT04000841 study?

This clinical trial studies the following conditions: Behavior.

What interventions are being tested in trial NCT04000841?

The interventions under investigation include: Mindful You mobile app (BEHAVIORAL).

Who is sponsoring clinical trial NCT04000841?

This trial is sponsored by IRIS Media, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04000841 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.